Skip to main content
# Title Department Research Member Research Year
551 Adjuvant Chemotherapy in High Risk Colon Cancer Standard FOLFOX or XELOX versus Short Duration of XELOX Department of Medical Oncology Dr. Mayada Fawzy Sedik Farghaly 2018
552 Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom Department of Pediatric Oncology Prof. Amany Mohamed Ali Ahmed 2018
553 New Look on Ureterocolic Diversion with Adjuvant Radiotherapy; SECI (South Egypt Cancer Institute) Experience Department of Surgical Oncology Dr. Ebraheem Abuelouoon Gaber Ali 2018
554 Comparison of nebulised dexmedetomidine, ketamine, or midazolam for premedication in preschool children undergoing bone marrow biopsy Department of Anesthesia, Intensive care and Pain management Dr. Fatma Adel Abd Diab. 2018
555 Author Correction: Strong associations between chromosomal aberrations in blood lymphocytes and the risk of urothelial and squamous cell carcinoma of the bladder. Department of Clinical Pathology Prof. Douaa Mohamed Sayed Hussein 2018
556 Risk-Adapted, Combined-Modality Therapy for
Unfavorable Pediatric Hodgkin Lymphom
Department of Clinical Pathology Dr. Samar Muhammad mansour 2018
557 Efficacy of Postoperative Analgesia of Local Ketamine
Wound Instillation Following Total Thyroidectomy
A Randomized, Double-blind, Controlled Clinical Trial
Department of Anesthesia, Intensive care and Pain management Dr. Ahmed Mohamed Abdel Rahman Osman 2018
558 Adjuvant Chemotherapy in High Risk Colon Cancer Standard FOLFOX or XELOX versus Short Duration of XELOX Department of Medical Oncology Dr. Mayada Fawzy Sedik Farghaly 2018
559 Frequency of ABCB1 Polymorphisms in Breast Cancer Patients in South Egypt Cancer Institute by High-Resolution Melting Curve Analysis
(Pilot Study)
Department of Clinical Pathology Prof. Hosny Badrawy Hamed Omran 2018
560 Signet ring carcinoma of the stomach: impact on prognosis and outcome
Department of Medical Oncology Dr. Hanaan Ahmed Mohammed Ahmed 2018